Cited by 4Protein Degradation and InhibitorsParasites and Host InteractionsTrypanosoma species research and implications

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Small Molecule Ligands of the BET-like Bromodomain, Sm BRD3, Affect Schistosoma mansoni Survival, Oviposition, and Development

Open access

Published version of a preprint

Abstract

Schistosomiasis is a disease affecting over 200 million people worldwide, but its treatment relies on a single agent, praziquantel. To investigate new avenues for schistosomiasis control, we have conducted the first systematic analysis of bromodomain-containing proteins (BCPs) in a causative species, Schistosoma mansoni. Having identified 29 putative bromodomains (BRDs) in 22 S. mansoni proteins, we selected SmBRD3, a tandem BRD-containing BCP that shows high similarity to the human bromodomain and extra terminal domain (BET) family, for further studies. Screening of 697 small molecules identified the human BET BRD inhibitor I-BET726 as a ligand for SmBRD3. An X-ray crystal structure of I-BET726 bound to the second BRD of SmBRD3 [SmBRD3(2)] enabled rationale design of a quinoline-based ligand (15) with an ITC Kd value of 364 ± 26.3 nM for SmBRD3(2). The ethyl ester pro-drug of compound 15 (compound 22) shows substantial effects on sexually immature larval schistosomula, sexually mature adult worms, and snail-infective miracidia in ex vivo assays. This compound will form the basis for future studies into new treatments for schistosomiasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.3c01321

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 73

  1. 10.1016/j.ijpara.2012.02.003 · DOI
  2. 10.1016/j.pt.2016.12.002 · DOI
  3. 10.1038/s41573-020-0077-5 · DOI
  4. 10.1016/j.cbpa.2018.06.015 · DOI
  5. 10.1038/s41594-019-0309-8 · DOI
  6. 10.1002/anie.201812164 · DOI
  7. 10.1021/acsinfecdis.1c00387 · DOI
  8. 10.1371/journal.ppat.1004116 · DOI
  9. 10.1371/journal.ppat.1005963 · DOI
  10. 10.1126/science.abb7699 · DOI
  11. 10.1038/s41572-018-0013-8 · DOI
  12. 10.1016/j.ijpddr.2018.10.005 · DOI
  13. 10.1016/j.cell.2012.06.045 · DOI
  14. 10.1021/acs.jmedchem.2c00453 · DOI
  15. 10.1016/j.cell.2012.02.013 · DOI
  16. 10.1016/j.molbiopara.2003.09.005 · DOI
  17. 10.1016/j.molbiopara.2005.12.006 · DOI
  18. 10.1016/j.actatropica.2007.11.006 · DOI
  19. 10.1371/journal.pntd.0007693 · DOI
  20. 10.1093/nar/gkac240 · DOI
  21. 10.1093/nar/gkt1223 · DOI · Paper page
  22. 10.1021/jm300915b · DOI
  23. 10.1016/j.febslet.2012.04.045 · DOI
  24. 10.1021/jm200108t · DOI
  25. 10.1038/nprot.2007.321 · DOI
  26. 10.1021/jm200640v · DOI
  27. 10.1021/jm301588r · DOI
  28. 10.1039/C2MD20189E · DOI
  29. 10.1002/anie.201402750 · DOI
  30. 10.1021/ja412434f · DOI
  31. 10.1002/anie.201602908 · DOI
  32. 10.1016/j.bmc.2018.05.003 · DOI
  33. 10.1002/cmdc.202000528 · DOI
  34. 10.1021/acs.jmedchem.1c00348 · DOI
  35. 10.1021/acsinfecdis.0c00618 · DOI
  36. 10.1021/jm5010539 · DOI
  37. 10.1038/nature09504 · DOI · Paper page
  38. 10.1016/j.cub.2006.12.037 · DOI
  39. 10.1021/cb500996u · DOI
  40. 10.1016/j.bmc.2017.10.042 · DOI
  41. 10.3390/pharmaceutics15051359 · DOI
  42. 10.1021/om100106e · DOI
  43. 10.1021/acs.analchem.6b04060 · DOI
  44. 10.1021/ac961242d · DOI
  45. 10.5599/admet.530 · DOI
  46. 10.1016/j.drudis.2011.06.001 · DOI
  47. 10.1002/ejoc.201800581 · DOI
  48. 10.1135/cccc19800517 · DOI
  49. 10.1021/ol901113t · DOI
  50. 10.1039/C1MD00201E · DOI
  51. 10.1007/s12038-016-9600-6 · DOI
  52. 10.1021/acs.jmedchem.6b01761 · DOI
  53. 10.1038/nrm.2016.143 · DOI
  54. 10.1016/j.molbiopara.2016.11.005 · DOI
  55. 10.1093/bioinformatics/btv362 · DOI
  56. 10.1101/308213 · DOI
  57. 10.1371/journal.pntd.0004334 · DOI
  58. 10.7554/eLife.00768 · DOI
  59. 10.1371/journal.pntd.0001455 · DOI
  60. 10.1371/journal.pntd.0005559 · DOI
  61. 10.1038/srep31150 · DOI
  62. 10.1016/0014-4894(74)90005-8 · DOI
  63. 10.1016/j.ijpddr.2018.10.009 · DOI
  64. 10.1016/j.ejmech.2021.113823 · DOI
  65. 10.1371/journal.pntd.0008630 · DOI
  66. 10.1021/acsinfecdis.1c00025 · DOI
  67. 10.1177/108705719900400206 · DOI · Paper page
  68. 10.1371/journal.pntd.0001762 · DOI
  69. 10.1371/journal.ppat.1009828 · DOI
  70. 10.1371/journal.pntd.0001494 · DOI
  71. 10.1371/journal.ppat.1007066 · DOI
  72. 10.1016/j.exppara.2009.12.021 · DOI
  73. 10.1016/j.exppara.2008.11.010 · DOI

Metadata

Authors
Schiedel, M., McArdle, D. J. B., Padalino, G., Chan, A. K. N., Forde-Thomas, J., McDonough, M., Whiteland, H., Beckmann, M., Cookson, R., Hoffmann, K. F., & Conway, S. J.
Affiliations
  • University of Oxford (GB)
  • Aberystwyth University (GB)
  • GlaxoSmithKline (United Kingdom) (GB)
  • University of California, Los Angeles (US)
Corresponding author
  • Hoffmann, Karl F.
  • Conway, Stuart J.
Venue
Journal of Medicinal Chemistry
Published
2023-12-04
Volume
66
Issue
23
Pages
15801-15822
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W4389302791
Cited by
4
References
1
Citations by year
2025: 1 · 2024: 2 · 2023: 1
FWCI
0.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Medicinal Chemistry (publishedVersion, cc-by)
  • ChemRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Cronfa (Swansea University) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Life Sciences Research Network Wales
  • University of California, Los Angeles
  • Deutsche Forschungsgemeinschaft (SCHI 1408/1-1)
  • GlaxoSmithKline
  • Horizon 2020 Framework Programme (660156)
  • St. Hugh's College, University of Oxford
  • Biotechnology and Biological Sciences Research Council (BB/S507015/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Health Sciences › Medicine › Epidemiology › Trypanosoma species research and implications
Keywords
bromodomain, small-molecule ligands, Schistosoma mansoni, schistosomiasis, parasite survival, oviposition, parasite development, antiparasitic drug discovery
MeSH terms
Aminoquinolines, Animals, Benzoates, Female, Humans, Ligands, Oviposition, Schistosoma mansoni, Schistosomiasis, Schistosomiasis mansoni

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review